| Dr Christopher Klem, MD | |
|
1380 Lusitana St, Physicians Office Building #1, Suite 502, Honolulu, HI 96813-2449 | |
| (808) 691-7215 | |
| (808) 691-7214 |
| Full Name | Dr Christopher Klem |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 26 Years |
| Location | 1380 Lusitana St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740296235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | D0060650 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Queens Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Queens Medical Center | 3476454067 | 187 |
News Archive
"The Obama administration said Tuesday that it will intensify efforts to fight discrimination against lesbians, gay men, bisexuals and transgender people as a major element of its foreign policy," the Washington Post reports.
Treatment with tyrosine kinase inhibitors does not appear to significantly impair health-related quality of life in Japanese patients with metastatic renal cell carcinoma, say researchers.
A research project carried out by a University of Southampton Masters student has identified three research challenges that will need to be addressed before pervasive healthcare becomes a reality.
EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.
› Verified 4 days ago
| Entity Name | The Queens Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693586 PECOS PAC ID: 3476454067 Enrollment ID: O20040116000366 |
News Archive
"The Obama administration said Tuesday that it will intensify efforts to fight discrimination against lesbians, gay men, bisexuals and transgender people as a major element of its foreign policy," the Washington Post reports.
Treatment with tyrosine kinase inhibitors does not appear to significantly impair health-related quality of life in Japanese patients with metastatic renal cell carcinoma, say researchers.
A research project carried out by a University of Southampton Masters student has identified three research challenges that will need to be addressed before pervasive healthcare becomes a reality.
EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Klem, MD 1380 Lusitana St, Physicians Office Building #1, Suite 502, Honolulu, HI 96813-2449 Ph: (808) 691-7215 | Dr Christopher Klem, MD 1380 Lusitana St, Physicians Office Building #1, Suite 502, Honolulu, HI 96813-2449 Ph: (808) 691-7215 |
News Archive
"The Obama administration said Tuesday that it will intensify efforts to fight discrimination against lesbians, gay men, bisexuals and transgender people as a major element of its foreign policy," the Washington Post reports.
Treatment with tyrosine kinase inhibitors does not appear to significantly impair health-related quality of life in Japanese patients with metastatic renal cell carcinoma, say researchers.
A research project carried out by a University of Southampton Masters student has identified three research challenges that will need to be addressed before pervasive healthcare becomes a reality.
EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.
› Verified 4 days ago
Jae H. Lim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Eric Daniel Wirtz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Road, Tripler Army Medical Center, Honolulu, HI 96859 Phone: 808-433-3181 | |
Dr. Kristi Adachi, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1380 Lusitana St Ste 502, Honolulu, HI 96813 Phone: 808-533-0711 Fax: 808-538-6763 | |
Dr. Marcelo A Obando, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. John Jung Wan Cho, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4530 Fax: 808-522-4529 | |
Charissa N. L. K. Kahue, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Patrick Joseph O'donnell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St Ste 1120, Honolulu, HI 96826 Phone: 808-983-6447 Fax: 808-983-8854 |